Showing 1-20 of 503 for: Cochrane Systematic Reviews > Neurologic 
- Acetylcholinesterase inhibitor treatment for myasthenia gravis
Cochrane Systematic Reviews, 13-Oct-2014
In myasthenia gravis, antibody-mediated blockade of acetylcholine receptors at the neuromuscular junction abolishes the naturally occurring ‘safety factor’ of synaptic transmission. Acetylcholinesterase inhibitors provide temporary symptomatic treatment o
- Acetyl‐l‐carnitine for dementia
Cochrane Systematic Reviews, 22-Apr-2003
Dementia is a common mental health problem affecting 5% of those over 65. Various pathological processes are linked to memory impairment in dementia, particularly those affecting the cholinergic neurotransmitter system. Acetyl-l-carnitine (ALC) is derived
- Acupuncture for Bell's palsy
Cochrane Systematic Reviews, 4-Aug-2010
Bell's palsy or idiopathic facial palsy is an acute facial paralysis due to inflammation of the facial nerve. A number of studies published in China have suggested acupuncture is beneficial for facial palsy.
- Acupuncture for epilepsy
Cochrane Systematic Reviews, 7-May-2014
Acupuncture is increasingly used in people with epilepsy. It remains unclear whether existing evidence is rigorous enough to support its use. This is an update of a Cochrane review first published in 2008.
- Acupuncture for insomnia
Cochrane Systematic Reviews, 12-Sep-2012
Although conventional non-pharmacological and pharmacological treatments for insomnia are effective in many people, alternative therapies such as acupuncture are widely practised. However, it remains unclear whether current evidence is rigorous enough to
- Acupuncture for the prevention of episodic migraine
Cochrane Systematic Reviews, 28-Jun-2016
Acupuncture is often used for migraine prevention but its effectiveness is still controversial. We present an update of our Cochrane review from 2009.
- Adenotonsillectomy for obstructive sleep apnoea in children
Cochrane Systematic Reviews, 29-Sep-2015
Current treatment of sleep apnoea in children consists of largely surgical based treatments. Adenotonsillectomy is the most commonly used intervention to treat sleep apnoea in children.
- Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas
Cochrane Systematic Reviews, 15-May-2014
Standard care of adjuvant treatment for anaplastic oligodendrogliomas (AO) and anaplastic oligoastrocytomas (AOA) is not yet well defined. The benefit of adjuvant chemotherapy and radiotherapy (RT), given as single modalities or sequentially, is still unc
- Aerobic exercise to improve cognitive function in older people without known cognitive impairment
Cochrane Systematic Reviews, 22-Apr-2015
There is increasing evidence that physical activity supports healthy ageing. Exercise is helpful for cardiovascular, respiratory and musculoskeletal systems, among others. Aerobic activity, in particular, improves cardiovascular fitness and, based on rece
- Air versus oxygen for resuscitation of infants at birth
Cochrane Systematic Reviews, 20-Apr-2005
100% oxygen is the commonly recommended gas for the resuscitation of infants at birth. There is growing evidence from both animal and human studies that room air is as effective as 100% oxygen and that 100% oxygen may have adverse effects on breathing phy
- Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy
Cochrane Systematic Reviews, 3-Nov-2008
Diabetic peripheral neuropathy is a common complication of diabetes mellitus.
- Aldose reductase inhibitors for the treatment of diabetic polyneuropathy
Cochrane Systematic Reviews, 17-Oct-2007
Polyneuropathy, a common complication of diabetes mellitus, causes pain and sensory and motor deficits in the limbs, and is also an important independent predictor of foot ulceration. Inhibiting the metabolism of glucose by the polyol pathway using aldose
- Alpha lipoic acid for dementia
Cochrane Systematic Reviews, 26-Jan-2004
Oxidative processes have been implicated in the pathogenesis of neurodegenerative dementias including Alzheimer's disease. Protecting the central nervous system against these damaging mechanisms may be a useful therapeutic approach. Alpha lipoic acid (ALA
- Amantadine for dyskinesia in Parkinson's disease
Cochrane Systematic Reviews, 22-Apr-2003
Abnormal involuntary movements known as dyskinesias are amongst the most disabling side-effects of levodopa therapy. It is thought that amantadine, an NMDA-receptor antagonist, may reduce dyskinesias in patients with Parkinson's disease without worsening
- Amantadine for fatigue in multiple sclerosis
Cochrane Systematic Reviews, 24-Jan-2007
Fatigue is one of the most common and disabling symptoms of people with Multiple Sclerosis (MS). The effective management of fatigue has an important impact on the patient's functioning, abilities, and quality of life. Although a number of strategies have
- Amantadine in Parkinson's disease
Cochrane Systematic Reviews, 20-Jan-2003
Although levodopa is the most common drug prescribed to relieve the symptoms of Parkinson's disease it is associated with motor and psychiatric side-effects. Consequently, interest has turned to alternative drugs with improved side-effect profiles to repl
- Amino acids for amyotrophic lateral sclerosis / motor neuron disease
Cochrane Systematic Reviews, 3-Nov-2008
Amyotrophic lateral sclerosis, also known as motor neuron disease, is a progressive neuromuscular disease that causes disability and eventual death. Various amino acid preparations, the three branched-chain amino acids (L-leucine, L-valine and L-isoleucin
- Aminopyridines for symptomatic treatment in multiple sclerosis
Cochrane Systematic Reviews, 21-Oct-2002
The potassium channel blockers 4-aminopyridine (AP) and 3,4-diaminopyridine (DAP) increase nerve conduction in demyelinated nerve fibers, and have been proposed as a symptomatic therapy for people with multiple sclerosis (MS).
- Aminosteroids for acute traumatic brain injury
Cochrane Systematic Reviews, 26-Jul-1999
Traumatic brain injury is a leading cause of premature death and disability. Post-traumatic membrane lipid peroxidation has been proposed as one mechanism leading to secondary brain damage following head injury. Aminosteroids have been shown to inhibit li
- Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization
Cochrane Systematic Reviews, 18-Apr-2007
Neonates from isoimmunized pregnancies have increased morbidity from neonatal jaundice. The increased bilirubin from haemolysis often needs phototherapy, exchange transfusion or both after birth. Various trials in pregnant women who were not isoimmunized
